Mathematical modelling of flow in 2D and 3D vascular networks: Applications to anti-angiogenic and chemotherapeutic drug strategies. (English) Zbl 1080.92050

Summary: The aim of this paper is to investigate the conditions required to optimize the amount of chemotherapeutic drug absorbed by a solid tumour through a network of blood vessels. This work is based on a study of vascular networks generated from a discrete mathematical model of tumour angiogenesis, which describes the formation of a capillary network in response to chemical stimuli released by a solid tumour. Simulations of blood flow in the vasculature connecting the parent vessel to the solid tumour are then performed by adapting modelling techniques from the field of petroleum engineering to this biomedical application.
We begin with a qualitative, comparative study relating to the efficiency of drug delivery in 2D and 3D tumour-induced vasculatures and evaluate the influence of key parameters (mean capillary radius, blood viscosity and delivery regime) upon uptake by the tumour. We then go on to examine the impact of the vascular architecture upon nutrient (e.g., oxygen) and drug delivery by comparing the efficiency of three vasculatures characterized by different spatial distributions of branching order and anastomosis density (i.e., the number of fused loops or connections). We identify the main criteria required of a tumour-induced vascular network for optimized delivery of nutrients and/or cytotoxic agents.
We conclude by focusing on a particular vascular network and investigate how “capillary pruning” (i.e., network re-modelling) modifies the network connectivity and associated blood flow distribution. We demonstrate how random removal of vessels may lead to a significant increase in the amount of drug delivered to the tumour. Selective removal of vessels characterized by low flow is seen to speed up delivery, whilst the targeting of high flow capillaries leads to a rapid shut down of the entire capillary bed. These results allow us to propose the possibility of optimized cancer treatment therapies, based upon a coupled anti-angiogenic/chemotherapy strategy. The anti-angiogenesis treatment would be used to optimize network efficiency, thereby maximizing drug uptake during subsequent chemotherapy treatments.


92C50 Medical applications (general)
92C35 Physiological flow
35Q92 PDEs in connection with biology, chemistry and other natural sciences
Full Text: DOI


[1] Anderson, A. R.A.; Chaplain, M. A.J., Continuous and discrete mathematical model of tumour-induced angiogenesis, Bull. Math. Biol., 60, 857-899 (1998) · Zbl 0923.92011
[2] McDougall, S. R.; Anderson, A. R.A.; Chaplain, M. A.J.; Sherratt, J. A., Mathematical modelling of flow through vascular networks: Implications for tumour-induced angiogenesis and chemotherapy strategies, Bull. Math. Biol., 64, 4, 673-702 (2002) · Zbl 1334.92106
[3] Risau, W., Mechanisms of angiogenesis, Nature, 386, 671-674 (1997)
[4] Walsh, D. A., Angiogenesis and arthritis, Rheumatology, 38, 103-112 (1999)
[5] Folkman, J., Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat. Med., 1, 21-31 (1995)
[6] Folkman, J., Tumor angiogenesis: Therapeutic implications, N. Engl. J. Med., 285, 1182-1186 (1971)
[7] Folkman, J.; Klagsbrun, M., Angiogenic factors, Science, 235, 442-447 (1987)
[8] Shoefl, G. I., Studies of inflammation III. Growing capillaries: Their structure and permeability, Virchows Arch. Path. Anat., 337, 97-141 (1963)
[9] Ausprunk, D. H.; Folkman, J., Migration and proliferation of endothelial cells in performed and newly formed blood vessels during tumour angiogenesis, Microvasc., 14, 53-65 (1977)
[10] Sholley, M. M.; Ferguson, G. P.; Seibel, H. R.; Montour, J. L.; Wilson, J. D., Mechamisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells, Lab. Invest., 51, 624-634 (1984)
[11] Gimbrone, M. A.; Cotran, R. S.; Leapman, S. B.; Folkman, J., Tumor growth and neovascularization: An Experimental model using the rabbit cornea, J. Natl. Cancer. Inst., 52, 413-427 (1974)
[12] Muthukkaruppan, V. R.; Kubari, L.; Auerbach, R., Tumor-induced neovascularization in the mouse eye, J. Natl. Cancer Inst., 69, 699-705 (1982)
[13] Jain, R. K., Transport of molecules in the tumour interstitium: A review, Cancer. Res., 47, 12, 3039-3051 (1987)
[14] Jain, R. K., Determinants of tumour blood flow: A review, Cancer Res., 48, 10, 2641-2658 (1988)
[15] Secomb, T. W.; Pries, A. R.; Gaehtgens, P., Architecture and hemodynamics of microvascular networks, (Jaffrin, M. Y.; Caro, C., Biological Flow (1995), Plenum Press), 159-176, 9
[16] Godde, R.; Kurz, H., Structural and biophysical simulation of angiogenesis and vascular remodelling, Developmental Dynamics, 220, 387-401 (2001)
[17] Krenz, G. S.; Dawson, C. A., Vessel distenbility and flow distribution in vascular trees, J. Math. Biol., 44, 360-374 (2002) · Zbl 0990.92011
[18] Baish, J. W.; Gazit, Y.; Berk, D. A.; Nozue, M.; Baxter, L. T.; Jain, R. K., Role of tumor vascular architecture in nutrient and drug delivery: An invasion percolation-based network model, Microvasc. Res., 51, 327-346 (1996)
[19] El-Kareh, A. W.; Secomb, T. W., Theoretical models for drug delivery to solid tumours, Crit. Rev. Biomed. Eng., 25, 6, 503-571 (1997)
[20] Jackson, T. L.; Lubkin, S. R.; Murray, J. D., Theoretical analysis of conjugate localization in two-step cancer chemotherapy, J. Math. Biol., 39, 353-376 (1999) · Zbl 0948.92011
[21] Quarteroni, A.; Tuveri, M.; Veneziani, A., Computational vascular fluid dynamics: Problems, models and methods, Comput. Visual. Sci., 2, 163-197 (2000) · Zbl 1096.76042
[22] Chaplain, M. A.J.; Anderson, A. R.A., Modelling the growth and form of capillary networks, (Chaplain, M. A.J.; Singh, G. D.; McLachlan, J. C., On Growth and Form: Spatio-temporal Pattern Formation in Biology (1999), Wiley: Wiley New York), 225-250 · Zbl 0935.92024
[23] Mitchell, A. R.; Griffiths, D. F., The Finite Difference Method in Partial Differential Equations (1980), Wiley: Wiley Chichester · Zbl 0417.65048
[24] Paweletz, N.; Knierim, M., Tumor-related angiogenesis, Crit. Rev. Oncol. Hematol., 9, 197-242 (1989)
[25] Sherratt, J. A.; Murray, J. D., Models of epidermal wound healing, (Proc. Roy. Soc. Lond., B241 (1990)), 29-36 · Zbl 0721.92010
[26] Bray, D., Cell Movements (1992), Garland Publishing: Garland Publishing Chichester
[27] McDougall, S. R.; Sorbie, K., The application of network modelling techniques to multiphase flow in porous media, Petroleum Geosci., 3, 161-169 (1997)
[28] Fung, Y. C., Biomechanics, Mechanical Properties of Living Tissues (1993), Springer-Verlag: Springer-Verlag New York
[29] Levick, J. R., An Introduction to Cardiovascular Physiology (2000), Arnold: Arnold New York
[30] Stauffer, D.; Aharony, A., Introduction to Percolation Theory, (Taylor; Francis (1992)), London · Zbl 1042.82556
[31] Kerbel, R. S., Tumor angiogenesis: Past, present and the near future, Carcinogenesis, 21, 3, 505-515 (2000)
[32] Hidalgo, M.; Eckhardt, S. G., Development of matrix metalloproteinase inhibitors in cancer therapy, J. Natl. Cancer Inst., 93, 3, 178-193 (2001)
[33] Ruhrberg, C., Endogenous inhibitors of angiogenesis, J. Cell Sci., 114, 3215-3216 (2001)
[34] Keshet, E.; Ben-Sasson, S. A., Anticancer drug targets: Approaching angiogenesis, J. Clin. Invest., 104, 11, 1497-1501 (1999)
[35] Benjamin, L. E.; Golijanin, D.; Itin, A.; Pode, D.; Keshet, E., Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal, J. Clin. Invest., 103, 2, 159-165 (1999)
[36] Darland, D. C.; D’Amore, P., Blood vessel maturation: Vascular development comes of age, J. Clin. Invest., 103, 2, 157-158 (1999)
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. It attempts to reflect the references listed in the original paper as accurately as possible without claiming the completeness or perfect precision of the matching.